Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studies
J Am Acad Dermatol. 2024 Oct;91(4):729-732.
doi: 10.1016/j.jaad.2024.05.077.
Epub 2024 Jun 7.
1 Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
2 Department of Dermatology, Stanford University School of Medicine, Stanford, California.
3 Dr. Philip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida.
4 Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
5 Department of Dermatology, Kyorin University Faculty of Medicine, Tokyo, Japan.
6 Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
7 Eli Lilly and Company, Indianapolis, Indiana.
8 Eli Lilly and Company, Indianapolis, Indiana. Electronic address: [email protected].
9 Department of Dermatology and Allergology, University Hospital, Ludwig-Maximilian University, Munich, Germany; Department of Dermatology and Allergy, Augsburg University Hospital, Augsburg, Germany.